A comprehensive view of Respiratory / Lung Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
European Commission approves Merck’s KEYTRUDA pembrolizumab plus chemotherapy as neoadjuvant treatment, then continued as monotherapy as adjuvant treatment, for resectable non-small cell lung cancer at high risk of recurrence in adults
Published:
March 28, 2024
by Business Wire
|
UNICEF delivers 254,000 Pfizer COVID-19 vaccine doses to Ukraine with support from GAVI; COVID-19, SARS and influenza have affected over 3.7 million Ukrainians since October 2023
Published:
March 28, 2024
by Interfax Ukraine Political News
|
Moderna announces Phase 3 success of next-gen COVID-19 vaccine, forthcoming flu combo vaccine, and progress in pivotal viral caccines set for 2024
Published:
March 28, 2024
by Industry Intelligence Inc.
|
US Patent Issued to AMOREPACIFIC on March 26 for "Composition for improving respiratory health continuously exposed to particulate matter atmosphere" (South Korean Inventors)
Published:
March 27, 2024
by U.S. Fed News
|
FTC files an amicus brief alleging that Teva improperly listed patents on its ProAir HFA asthma inhaler in the FDA Orange Book, blocking Amneal's approval for a generic version; the FTC is seeking a court judgement to make Teva retract the patents
Published:
March 25, 2024
by FiercePharma
|
Ask us about our Consumer Wellness market view